Table 1.
5-Year Total | % of Tumors | Median Age | M:F Annual | |
---|---|---|---|---|
Meningioma | 152,756 | 37.6% | 66.0 | 1:2.72 |
Sellar Region Tumors | 71,084 | 17.5% | 51.0 | 1:1.20 |
Glioblastoma | 59,164 | 14.6% | 65.0 | 1.37:1 |
Nerve Sheath Tumors | 35,017 | 8.6% | 56.0 | 1:1.09 |
Unclassified Tumors | 20,556 | 5.1% | 63.0 | 1:1.20 |
Lymphoma | 7680 | 1.9% | 66.0 | 1.02:1 |
Diffuse Astrocytoma | 7500 | 1.8% | 47.0 | 1.22:1 |
Anaplastic Astrocytoma | 7015 | 1.7% | 53.0 | 1.23:1 |
Ependymal Tumors | 6877 | 1.7% | 45.0 | 1.32:1 |
Pilocytic Astrocytoma | 5166 | 1.3% | 12.0 | 1.08:1 |
Oligodendroglioma | 3668 | 0.9% | 43.0 | 1.21:1 |
Embryonal Tumors | 3493 | 0.9% | 8.0 | 1.41:1 |
Germ Cell Tumors | 1543 | 0.4% | 16.0 | 2.18:1 |
Choroid Plexus Tumors | 817 | 0.2% | 36.0 | 1.01:1 |
Pineal Region Tumors | 796 | 0.2% | 34.5 | 1:1.34 |
Based on CBTRUS Statistical Report: U.S. Cancer Statistics—NPCR and SEER 2012–2016. These values make up 94.4% of tumors from the data collected from 2012–2016.